Compare NetApp Inc. (NTAP) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetApp Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? NetApp Inc. trades at $166.94 (market cap $31.57B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: NetApp Inc. pays a 1.29% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| NTAP | XBI | |
|---|---|---|
Market Cap | $31.57B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $181.08 | $164.28 |
52-Week Low | $94.11 | $85.16 |
Enterprise Value | $30.72B | — |
Dividend Yield | 1.29% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
